mTOR Inhibitors: EVEROLIMUS, TEMSIROLIMUS
Pharmacokinetics
- oral administration; must be taken consistently (either with or without food) in order to minimize variability in drug concentration
- metabolized by CYP 3A4 (drug interactions)
- substrate for P-glycoprotein